HIGHLIGHTS
- who: Nur Hezrin Shahrin from the Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, South Australia, Australia have published the paper: Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication, in the Journal: (JOURNAL)
- what: Maintaining patients in chronic phase CML is essential to avoid CML-induced death, yet we lack accurate predictive tools to inform therapeutic choices.
SUMMARY
The initiating event is a reciprocal fusion of chromosomes 9 and 22 in hematopoietic stem_cells. At BP, which can appear as a myeloid or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.